Chonghao Wang

Chonghao Wang

Auto-generated profile, based on publicly available information

Chonghao Wang

Hong Kong Baptist University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2025 in IEEE Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Open access
XYXiangzhe Yuan
Xiangzhe Yuan
CWChonghao Wang
Chonghao Wang
SZShuqin Zhu
Shuqin Zhu
LZLu Zhang
Lu Zhang
Polygenic risk scoring (PRS) holds promise for improving disease prediction and medical treatments by evaluating an individual's genetic susceptibility through multiple genetic variants. However, current PRS calculation methods often excel only in specific diseases and populations, with no single approach consistently outperforming others across all contexts. Furthermore, these methods frequently overlook non-genetic factors, such as lifestyle, that also impact disease risk.We introduce an unsupervised Deep Belief Network (DBN) to aggregate PRS generated by various methods, achieving performance comparable to the Super Learner method'a supervised ensemble approach that combines predictions from multiple methods to improve outcomes. Unlike supervised methods, the DBN does not require training data and can directly ensemble the available PRS. Remarkably, on small-scale datasets, the DBN outperforms the Super Learner. Additionally, we present the DBNX model, which integrates PRS with non-genetic factors using a combination of DBN and XGBoost. DBNX produces a Composite Risk Score (CRS) that incorporates information from both PRS and non-genetic factors. In our experiments using the UK Biobank (UKBB) dataset across four diseases, DBNX demonstrated superior performance compared to other commonly used ensemble methods. The codes for DBNX are available at: https://github.com/Hangzen/DBNX

31 July 2025 in bioRxiv
Verified
Preprint
Open access
CWChonghao Wang
Chonghao Wang
LZLu Zhang
Lu Zhang
Persistent emergence of viral variants capable of evading host immunity constitutes a significant threat to public health. This antigenic evolution frequently outpaces the development of vaccines and therapeutics, highlighting the necessity of predictive models surveilling the immune escape potential of emerging variants. However, existing models suffer from two key limitations: they inadequately incorporate protein structural information and neglect the importance of distinguishing large-impact mutations from neutral ones given multiple mutations. To address these gaps, we presented KEScape, a deep learning model designed to predict viral immune escape and evolution. KEScape integrates evolutionary context with protein structural information, introduces a novel top-K L 2 -differential pooling mechanism to prioritize mutations with large functional effects, and incorporates a supervised L 2 margin loss to facilitate the L 2 -distance-based ranking of high-impact mutations. We demonstrated that KEScape significantly outperformed state-of-the-art models on the most comprehensive benchmark to date, comprising eleven deep mutational scanning experiments spanning diverse viruses. Furthermore, KEScape exhibited outstanding performance in the practical applications of identifying immune escape hotspots and variants in emerging lineages and real-time surveillance of lineages associated with WHO-designated variants of SARS-CoV-2. These results show that KEScape is an effective model to predict viral immune escape and evolution. Its capacity for early warning can directly inform public health interventions and guide the development of countermeasures, thereby mitigating the threat of future viral pandemics.

31 March 2026 in IEEE Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Closed access
CWChonghao Wang
Chonghao Wang
WVWerner Pieter Veldsman
Werner Pieter Veldsman
YHYufen Huang
Yufen Huang
XFXiaodong Fang
Xiaodong Fang
LZLu Zhang
Lu Zhang
Rare diseases affect millions of individuals worldwide, yet diagnostic yields for them still remain low. Among variant identification approaches, identity by descent (IBD) mapping is used to identify disease susceptible variants originating from a recent common ancestor among affected individuals, but existing IBD detection models struggle to identify these variants in short IBD segments. Here, we introduce SILO, a novel model to detect disease susceptible variants in both short and long IBD segments. SILO employs a two-stage procedure to detect IBD segments. In the first stage, SILO identifies long IBD segments based on common variants. In the second stage, SILO utilizes rare variants to detect short IBD segments using a seed-and-extend algorithm. We evaluated SILO in simulated data and real data from the 1000 Genomes Project. Our results demonstrate that SILO outperforms existing models in detecting disease susceptible variants within short IBD segments, and show comparable performance in detecting these variants within longer IBD segments. These findings highlight the potential of SILO to increase diagnostic yields for rare diseases by enhancing the identification of previously overlooked disease susceptible variants in short IBD segments. Nonetheless, we note that the detection of short IBD segments remains challenging due to limited precision, leaving room for future improvement.

22 November 2024
Verified
Conference Paper
Open access
ZLZeming Li
Zeming Li
YXYu Xu
Yu Xu
DCDebajyoti Chowdhury
Debajyoti Chowdhury
HYHip Fung Yip
Hip Fung Yip
CWChonghao Wang
Chonghao Wang
LZLu Zhang
Lu Zhang
Predicting complex diseases using computational methods have rapidly evolved, which accelerates precision medicine, disease prevention, and so on. In past years, especially after emergence of genomics, major focus was inclined connecting genetic influence to complex diseases wherein many other essential factors such as environment, lifestyles, and so on were constantly neglected. In recent years, researchers have begun predicting disease risk scores by integrating genetic variants data and different lifestyle factors (alcohol intake, etc) and physical parameters (body mass index, age, etc). However, a potential missing link still exists there as most of those methods did not adequately address how to integrate the information from the medical history record that plays a crucial role in complex disease occurrence. In this paper, we have proposed Med-PRSIMD model that integrates genetic variants, lifestyle factors and medical history records to advance complex disease prediction. In this approach, we trained the Transformer model using causal language model pretraining task for extracting medical history records information. We have evaluated the prediction performance of our proposed Med-PRSIMD model on coronary artery disease, type 2 diabetes, and breast cancer patients' data obtained from the UK biobank. Med-PRSIMD achieved state-of-the-art performance compared to existing methods.

29 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
CWChonghao Wang
Chonghao Wang
YXYu Xu
Yu Xu
ZLZeming Li
Zeming Li
LZLouxin Zhang
Louxin Zhang
LZLu Zhang
Lu Zhang
Many phage proteins remain functionally uncharacterized despite advances in structural-similarity-based annotation. We introduce PhageFlare, a deep learning framework for predicting phage protein functions lacking significant structural matches to annotated references. Across three structure-disjoint benchmarks, where no significant Foldseek match was detected between training and test proteins (E-value thresholds of 10 − 3 , 10 − 4 , and 10 − 2 ), PhageFlare achieved macro-averaged F 1 scores of 0.871, 0.889, and 0.738 outperforming the strongest baseline (0.789, 0.814, and 0.732). Systematic evaluations demonstrated that protein language model selection critically influences performance, with ESM-C achieving stronger overall performance than ESM-2 and ProtBert. Embedding-guided case studies revealed local structural correspondences among proteins with limited global similarity. Applied to the efam and Metagenomic Gut Virus datasets, PhageFlare annotated 38.0% and 51.8% of proteins unresolved by Fold-seek, respectively. Furthermore, PhageFlare identified lysogenic potential in 1,866 prophage-designated genomes misclassified as lytic by BACPHLIP. These results show that PhageFlare complements structural-similarity-based annotation and expands functional discovery across viral dark matter.